Armata Pharmaceuticals, Inc. (ARMP) vs Korro Bio, Inc. (KRRO)
Armata Pharmaceuticals, Inc. and Korro Bio, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Korro Bio, Inc. are of similar size ($140.9M and $136.5M). Armata Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −19.3% against −81.9%. Korro Bio, Inc. has the higher net margin (0.00% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 15 metrics below, Korro Bio, Inc. leads on 9 and Armata Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | ARMP | KRRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (734.19%) | 0.00% | 0.00% |
| Net margin | (3,467.04%) | 0.00% | 0.00% |
| Free cash flow margin | (465.34%) | 0.00% | 0.00% |
| Return on equity | 127.83% | (97.69%) | (57.72%) |
| Return on assets | (225.11%) | (62.03%) | (49.22%) |
| Return on invested capital | (89.61%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack